Skip to main content
. 2020 Aug 25;10(4):124–133.

Figure 1.

Figure 1

OS (A) of the entire cohort and (B) according to treatment intensity post-RR-AML. BSC: best supportive care; CI: confidence interval; IT: intensive therapy; NIT: non-intensive therapy; NR: not reached; OS: overall survival; RR-AML: relapsed/refractory acute myeloid leukemia. *P<0.001 between IT, NIT, and BSC groups.